Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

PHASE3CompletedINTERVENTIONAL
Enrollment

566

Participants

Timeline

Start Date

July 23, 2018

Primary Completion Date

November 11, 2020

Study Completion Date

October 18, 2021

Conditions
Diabetic Macular Edema
Interventions
DRUG

Brolucizumab

Intravitreal injection

DRUG

Aflibercept

Intravitreal injection

Trial Locations (116)

1090

Novartis Investigative Site, Vienna

1425

Novartis Investigative Site, CABA

2000

Novartis Investigative Site, Sydney

2145

Novartis Investigative Site, Westmead

2150

Novartis Investigative Site, Parramatta

2170

Novartis Investigative Site, Liverpool

3002

Novartis Investigative Site, Melbourne

3168

Novartis Investigative Site, Clayton

5000

Novartis Investigative Site, Adelaide

6009

Novartis Investigative Site, Nedlands

6020

Novartis Investigative Site, Innsbruck

19107

Novartis Investigative Site, Philadelphia

20100

Novartis Investigative Site, Milan

20132

Novartis Investigative Site, Milan

32503

Novartis Investigative Site, Pensacola

33136

Novartis Investigative Site, Miami

34994

Novartis Investigative Site, Stuart

35128

Novartis Investigative Site, Padua

37232

Novartis Investigative Site, Nashville

38119

Novartis Investigative Site, Memphis

42001

Novartis Investigative Site, Paducah

44122

Novartis Investigative Site, Cleveland

44195

Novartis Investigative Site, Cleveland

45242

Novartis Investigative Site, Cincinnati

46014

Novartis Investigative Site, Valencia

46280

Novartis Investigative Site, Indianapolis

47011

Novartis Investigative Site, Valladolid

47150

Novartis Investigative Site, New Albany

50009

Novartis Investigative Site, Zaragoza

60187

Novartis Investigative Site, Wheaton

61801

Novartis Investigative Site, Urbana

66100

Novartis Investigative Site, Chieti

66211

Novartis Investigative Site, Leawood

66215

Novartis Investigative Site, Lenexa

75701

Novartis Investigative Site, Tyler

77030

Novartis Investigative Site, Houston

77401

Novartis Investigative Site, Bellaire

78240

Novartis Investigative Site, San Antonio

78550

Novartis Investigative Site, Harlingen

78705

Novartis Investigative Site, Austin

78731

Novartis Investigative Site, Austin

78750

Novartis Investigative Site, Austin

80909

Novartis Investigative Site, Colorado Springs

85053

Novartis Investigative Site, Phoenix

89502

Novartis Investigative Site, Reno

90211

Novartis Investigative Site, Beverly Hills

92093

Novartis Investigative Site, La Jolla

93103

Novartis Investigative Site, Santa Barbara

94040

Novartis Investigative Site, Mountain View

95124

Novartis Investigative Site, Catania

95403

Novartis Investigative Site, Kingston

96701

Novartis Investigative Site, ‘Aiea

98383

Novartis Investigative Site, Silverdale

99204

Novartis Investigative Site, Spokane

110221

Novartis Investigative Site, Bogotá

3109601

Novartis Investigative Site, Haifa

3339419

Novartis Investigative Site, Haifa

3436212

Novartis Investigative Site, Haifa

4428164

Novartis Investigative Site, Kfar Saba

4941492

Novartis Investigative Site, Petah Tikva

6423906

Novartis Investigative Site, Tel Aviv

7610001

Novartis Investigative Site, Rehovot

9112001

Novartis Investigative Site, Jerusalem

06810

Novartis Investigative Site, Danbury

01107

Novartis Investigative Site, Springfield

02180

Novartis Investigative Site, Stoneham

53705-3611

Novartis Investigative Site, Madison

C1015ABO

Novartis Investigative Site, Ciudad Autonoma de Bs As

Unknown

Novartis Investigative Site, Rosario

Novartis Investigative Site, CABA

Novartis Investigative Site, Medellín

Novartis Investigative Site, Kumamoto

X5000AAJ

Novartis Investigative Site, Córdoba

A-8036

Novartis Investigative Site, Graz

K1Z 8R2

Novartis Investigative Site, Ottawa

M4N 3M5

Novartis Investigative Site, Toronto

M5C 2T2

Novartis Investigative Site, Toronto

G1S 4L8

Novartis Investigative Site, Québec

001

Novartis Investigative Site, Medellín

00144

Novartis Investigative Site, Roma

455-8530

Novartis Investigative Site, Nagoya

457-8511

Novartis Investigative Site, Nagoya

462-0825

Novartis Investigative Site, Nagoya

466 8560

Novartis Investigative Site, Nagoya

830-8543

Novartis Investigative Site, Kurume

660 8550

Novartis Investigative Site, Amagasaki

300-0817

Novartis Investigative Site, Tsuchiura

315-0037

Novartis Investigative Site, Ishioka

890 8520

Novartis Investigative Site, Kagoshima

390-8621

Novartis Investigative Site, Matsumoto

336-0963

Novartis Investigative Site, Saitama-shi

329-0498

Novartis Investigative Site, Shimotsuke

101-8309

Novartis Investigative Site, Chiyoda-ku

193-0944

Novartis Investigative Site, Hachiōji

162 8666

Novartis Investigative Site, Shinjuku Ku

111-0051

Novartis Investigative Site, Taito-ku

543-0027

Novartis Investigative Site, Osaka

1105 AZ

Novartis Investigative Site, Amsterdam

3011 BH

Novartis Investigative Site, Rotterdam

5022 GC

Novartis Investigative Site, Tilburg

3000-548

Novartis Investigative Site, Coimbra

3030-363

Novartis Investigative Site, Coimbra

2410-187

Novartis Investigative Site, Leiria

4099-001

Novartis Investigative Site, Porto

4200 319

Novartis Investigative Site, Porto

4520 211

Novartis Investigative Site, Santa Maria da Feira

2600-009

Novartis Investigative Site, Vila Franca de Xira

00612

Novartis Investigative Site, Arecibo

08036

Novartis Investigative Site, Barcelona

08190

Novartis Investigative Site, Sant Cugat del Vallès

08025

Novartis Investigative Site, Barcelona

GU16 7UJ

Novartis Investigative Site, Frimley

B18 7QH

Novartis Investigative Site, Birmingham

HU3 2JZ

Novartis Investigative Site, Hull

NW10 7NS

Novartis Investigative Site, London

NG7 2UH

Novartis Investigative Site, Nottingham

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY